Abstract:COVID‐19 can survive from hours to months in environment. Nanoparticles (NPs) utilize in various medical applications, including antiviral treatment. In this study, silver (Ag), copper oxide (CuO), cobalt oxide (Co3O4), and cerium oxide (CeO2) NPs besides Ag and Cu sheets show antiviral activity against COVID‐19 while Cu NPs and Cu sheet has more destructive effects than others. COVID‐19 the most devastating pandemic of the current millennium, can survive from hours to months in environment, devices, and surface. Its transmission by asymptomatic carriers has significantly strained the existing testing resources. At present, there are no clinically proven therapeutic methods that effectively inhibit the effects of this virus. Nanoparticles (NPs) have been extensively utilized in various medical applications, including biosensing, drug delivery, imaging, and antimicrobial/antiviral treatment. Synthetic NPs can closely resemble the virus and strongly interact with its proteins due to their similar morphology. Therefore, NP‐based strategies for combating this virus hold immense potential and may reduce the survivability of the virus in the environment due to unique physicochemical features and surface modification properties. In this study, antiviral properties of silver (Ag), copper oxide (CuO), cobalt oxide (Co3O4), and cerium oxide (CeO2) NPs besides Ag and Cu sheets against COVID‐19 in nasopharyngeal samples were investigated. All NPs suspensions were prepared in Virus Transporter Media (VTM) in 25, 50, and 100 mg/mL concentrations, additionally, Cu and Ag sheets were added to SARS‐CoV‐2 virus pooled and then incubated at room temperature. Viral RNA was extracted from those suspensions after different incubation times and concentrations and quantitative polymerase chain reaction (qPCR) analysis was performed. For virucidal activity evaluation, the estimated lysed virus copy number was assessed according to the pooled virus sample serial dilution and eventually based on changes in the cycle threshold (CT) of qPCR. According to CT number changing after incubation of NPs with pooled virus sample, CuO NPs had the greatest virus inactivation on virus lysis at all concentrations and times while Co3O4 NPs showed moderate antiviral activity (P<0.05). The antiviral activity of other NPs was less than CuO and Co3O4 and were almost identical at similar concentrations and times. Cu and Ag sheets have shown a direct linear relationship between incubation time and antiviral activity. Cu nanoparticles had significant destructive effects on the SARS‐CoV‐2 virus among all nanoparticles, and the Cu sheet had considerably less antiviral activity than its own Cu NPs. These findings might make it helpful to use CuO NPs in masks, and air/water filters, make coated surfaces with effective NPs, and manufacture disinfectant solutions to combat coronaviruses and other viruses that can cause respiratory infections.

Adsorption of Favipiravir as Drug of Coronavirus Disease on Cu-Si52, Cu-C52, Cu-Al26N26, Cu-SiNT (6, 0), Cu-CNT (6, 0) and Cu-AlNT (6, 0)

Examination of Potential of Fe-Si78, Fe-C78, Fe-B39P39, Fe-SiNT (9, 0), Fe-CNT (9, 0) and Fe-BPNT (9, 0) to Deliver the Chloroquine as Drug of Coronavirus Disease

Theoretical Investigation of Drug Delivery of Cimetidine as Drug of Coronavirus Disease by Silicon Nanotubes and Silicon Nanocages

Nanosheets (CC-BC3-C3N) as an carrier for favipiravir drug: A density functional theory study

Identification of potent COVID-19 main protease inhibitors by loading of favipiravir on Mg12O12 and Zn12O12 nanoclusters: an in silico strategy for COVID-19 treatment

Unveiling the Potential of B3O3 Nanoflake as Effective Transporter for the Antiviral Drug Favipiravir: Density Functional Theory Analysis

Temperature-Responsive Multilayer Films Based on Block Copolymer-Coated Silica Nanoparticles for Long-Term Release of Favipiravir

A DFT study on the adsorption behavior of antiviral Favipiravir drug on B N (n = 12, 16, 20, and 24) nanocages: The size effect

A novel nanocomposite drug delivery system for SARS-CoV-2 infections

Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations

A new insight into the transfer and delivery of anti-SARS-CoV-2 drug Carmofur with the assistance of graphene oxide quantum dot as a highly efficient nanovector toward COVID-19 by molecular dynamics simulation

Antiviral Effects of Silver, Copper Oxide, Cerium Oxide, and Cobalt Oxide Nanoparticles and Silver and Copper Sheets Against COVID‐19

Spectroscopic characterization and quantum chemical calculations on Favipiravir-Guanine biomolecular complex

In situ synthesis of multivariant zeolitic tetrazolate imidazole frameworks (ZTIFs) with uncoordinated N-heteroatom sites for efficient adsorption of antiviral drugs

Anti-Influenza Virus Study of Composite Material with MIL-101(Fe)-Adsorbed Favipiravir

Construction of a Voltammetric Sensor Based on Niobium Supported on Zirconium Oxide‐Carbon Nanotubes for the Determination of Favipiravir, an Antiviral Drug Used Against Covid‐19

Spherical PEG/SiO2 promising agents for Lamivudine antiviral drug delivery, a molecular dynamics simulation study

Surface enhanced Raman scattering investigation of tecovirimat on silver, gold and platinum loaded silica nanocomposites: Theoretical analysis (DFT) and molecular modeling

Investigation of substituent effects on the electronic structure and antiviral activity of favipiravir derivatives for Covid-19 treatment using DFT and molecular docking

An Innovative Polymer-Based Electrochemical Sensor Encrusted with Tb Nanoparticles for the Detection of Favipiravir: A Potential Antiviral Drug for the Treatment of COVID-19

Synergistic effect of gold nanoparticles anchored on conductive carbon black as an efficient electrochemical sensor for sensitive detection of anti-COVID-19 drug Favipiravir in absence and presence of co-administered drug Paracetamol